|
Volumn 43, Issue 4, 2014, Pages 386-387
|
Minocycline is a reliable and effective oral option to treat meticillin-resistant Staphylococcus aureus skin and soft-tissue infections, including doxycycline treatment failures
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CEFTAROLINE;
CEPHALOSPORIN DERIVATIVE;
COTRIMOXAZOLE;
DOXYCYCLINE;
LINEZOLID;
MINOCYCLINE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RIFAMPICIN;
ANTIINFECTIVE AGENT;
ANTIBIOTIC RESISTANCE;
AUTOIMMUNE HEPATITIS;
BACTERIAL ENDOCARDITIS;
BACTERIAL SKIN DISEASE;
DIZZINESS;
DRUG TREATMENT FAILURE;
FLU LIKE SYNDROME;
HEPATITIS;
HUMAN;
HYPERPIGMENTATION;
LETTER;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION;
PRIORITY JOURNAL;
PROSTHESIS INFECTION;
SKIN ABSCESS;
SOFT TISSUE INFECTION;
SYSTEMIC LUPUS ERYTHEMATOSUS;
THROMBOCYTOPENIA;
COMMUNITY-ACQUIRED INFECTIONS;
DRUG EFFECTS;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
SOFT TISSUE INFECTIONS;
STAPHYLOCOCCAL SKIN INFECTIONS;
ANTI-BACTERIAL AGENTS;
COMMUNITY-ACQUIRED INFECTIONS;
HUMANS;
METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;
MINOCYCLINE;
SOFT TISSUE INFECTIONS;
STAPHYLOCOCCAL SKIN INFECTIONS;
|
EID: 84898008085
PISSN: 09248579
EISSN: 18727913
Source Type: Journal
DOI: 10.1016/j.ijantimicag.2014.01.003 Document Type: Letter |
Times cited : (5)
|
References (10)
|